JPMorgan Chase & Co. - Net Worth and Insider Trading
JPMorgan Chase & Co. Net Worth
The estimated net worth of JPMorgan Chase & Co. is at least $69 Million dollars as of 2025-05-25. JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Joinn Laboratories (China) Co Ltd and owns about 6,016,210 shares of Joinn Laboratories (China) Co Ltd (HKSE:06127) stock worth over $69 Million. Details can be seen in JPMorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that JPMorgan Chase & Co. has not made any transactions after 2023-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of JPMorgan Chase & Co.
JPMorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, JPMorgan Chase & Co. owns 1 companies in total, including Joinn Laboratories (China) Co Ltd (HKSE:06127) .
Click here to see the complete history of JPMorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of JPMorgan Chase & Co.
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:06127 | Joinn Laboratories (China) Co Ltd | 2023-09-14 | 2201 Interest of corporation controlled by you |
JPMorgan Chase & Co. Latest Holdings Summary
JPMorgan Chase & Co. currently owns a total of 1 stock. JPMorgan Chase & Co. owns 6,016,210 shares of Joinn Laboratories (China) Co Ltd (HKSE:06127) as of September 14, 2023, with a value of $69 Million.
Latest Holdings of JPMorgan Chase & Co.
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:06127 | Joinn Laboratories (China) Co Ltd | 2023-09-14 | 6,016,210 | 11.40 | 68,584,794 |
Holding Weightings of JPMorgan Chase & Co.
JPMorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, JPMorgan Chase & Co. has made a total of 40 transactions in Joinn Laboratories (China) Co Ltd (HKSE:06127) over the past 5 years, including 6 buys and 3 sells. The most-recent trade in Joinn Laboratories (China) Co Ltd is the acquisition of 377,978 shares on September 14, 2023, which cost JPMorgan Chase & Co. around $5 Million.
Insider Trading History of JPMorgan Chase & Co.
- 1
JPMorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of JPMorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by JPMorgan Chase & Co. is 7.95%. GuruFocus also compares JPMorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by JPMorgan Chase & Co. within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how JPMorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of JPMorgan Chase & Co.
JPMorgan Chase & Co. Ownership Network
Ownership Network List of JPMorgan Chase & Co.
Ownership Network Relation of JPMorgan Chase & Co.

JPMorgan Chase & Co. Owned Company Details
What does Joinn Laboratories (China) Co Ltd do?
Who are the key executives at Joinn Laboratories (China) Co Ltd?
JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Joinn Laboratories (China) Co Ltd. Other key executives at Joinn Laboratories (China) Co Ltd include 2102 Investment manager yi fang da ji jin guan li you xian gong si , 2301 Trustee Futu Trustee Limited , and 2201 Interest of corporation controlled by you Ubs Group Ag .
Joinn Laboratories (China) Co Ltd (HKSE:06127) Insider Trades Summary
Over the past 18 months, JPMorgan Chase & Co. made no insider transaction in Joinn Laboratories (China) Co Ltd (HKSE:06127). Other recent insider transactions involving Joinn Laboratories (China) Co Ltd (HKSE:06127) include a net sale of 24,500 shares made by Ubs Group Ag , a net sale of 1,965,800 shares made by FIL Limited , and a net sale of 1,965,800 shares made by Pandanus Partners L.P. .
In summary, during the past 3 months, insiders sold 3,064,300 shares of Joinn Laboratories (China) Co Ltd (HKSE:06127) in total and bought 521,900 shares, with a net sale of 2,542,400 shares. During the past 18 months, 11,990,330 shares of Joinn Laboratories (China) Co Ltd (HKSE:06127) were sold and 2,700,800 shares were bought by its insiders, resulting in a net sale of 9,289,530 shares.
Joinn Laboratories (China) Co Ltd (HKSE:06127)'s detailed insider trading history can be found in Insider Trading Tracker table.
Joinn Laboratories (China) Co Ltd Insider Transactions
JPMorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for JPMorgan Chase & Co.. Currently GuruFocus does not have mailing address information for JPMorgan Chase & Co..